Patents/Assignees

Io Therapeutics, Inc.

10 patents in portfolio

US12325685utility2025
RXR Agonist Salt Form, Polymorphs Thereof, and Uses Thereof
0 cites
US12115193utility2024
Methods of Using Rarγ Agonists for Cancer Treatment
0 cites
US11976021utility2024
Synthesis of Tetrahydronaphthalenols and Uses Thereof
0 cites
US11919848utility2024
RXR Agonist Salt Form, Polymorphs Thereof, and Uses Thereof
0 cites
US11793835utility2023
Methods of Using Rarγ Agonists for Cancer Treatment
0 cites
US11786555utility2023
RAR Selective Agonists in Combination with Immune Modulators for Cancer Immunotherapy
0 cites
US11779558utility2023
Receptor Subtype and Function Selective Retinoid and Rexinoid Compounds in Combination with Immune Modulators for Cancer Immunotherapy
0 cites
US11737996utility2023
Immunomodulatory and Differentiating Function Selective Retinoid and Rexinoid Compounds in Combination with Immune Modulators for Cancer Immunotherapy
0 cites
US11690831utility2023
Treatment of Autoimmune Diseases with Combinations of RXR Agonists and Thyroid Hormones
0 cites
US11648223utility2023
Receptor Subtype and Function Selective Retinoid and Rexinoid Compounds in Combination with Immune Modulators for Cancer Immunotherapy
0 cites